TY  - JOUR
AU  - Cardoso, Rafael
AU  - Guo, Feng
AU  - Heisser, Thomas
AU  - De Schutter, Harlinde
AU  - Van Damme, Nancy
AU  - Nilbert, Mef Christina
AU  - Christensen, Jane
AU  - Bouvier, Anne-Marie
AU  - Bouvier, Véronique
AU  - Launoy, Guy
AU  - Woronoff, Anne-Sophie
AU  - Cariou, Mélanie
AU  - Robaszkiewicz, Michel
AU  - Delafosse, Patricia
AU  - Poncet, Florence
AU  - Walsh, Paul M
AU  - Senore, Carlo
AU  - Rosso, Stefano
AU  - Lemmens, Valery E P P
AU  - Elferink, Marloes A G
AU  - Tomšič, Sonja
AU  - Žagar, Tina
AU  - Marques, Arantza Lopez de Munain
AU  - Marcos-Gragera, Rafael
AU  - Puigdemont, Montse
AU  - Galceran, Jaume
AU  - Carulla, Marià
AU  - Sánchez-Gil, Antonia
AU  - Chirlaque, María-Dolores
AU  - Hoffmeister, Michael
AU  - Brenner, Hermann
TI  - Overall and stage-specific survival of patients with screen-detected colorectal cancer in European countries: A population-based study in 9 countries.
JO  - The lancet / Regional health. Europe
VL  - 21
SN  - 2666-7762
CY  - [Amsterdam]
PB  - Elsevier
M1  - DKFZ-2022-01468
SP  - 100458
PY  - 2022
N1  - #EA:C120#LA:C120#LA:C070#
AB  - An increasing proportion of colorectal cancers (CRCs) are detected through screening due to the availability of organised population-based programmes. We aimed to analyse survival probabilities of patients with screen-detected CRC in European countries.Data from CRC patients were obtained from 16 population-based cancer registries in nine European countries. We included patients with cancer diagnosed from the year organised CRC screening programmes were introduced until the most recent year with available data at the time of analysis, whose ages at diagnosis fell into the age groups targeted by screening. Patients were followed up with regards to vital status until 2016-2020 across the various countries. Overall and CRC-specific survival were analysed by mode of detection and stage at diagnosis for all countries combined and for each country separately using the Kaplan-Meier method.We included data from 228 134 patients, of whom 134 597 (aged 60-69 years at diagnosis targeted by screening in all countries) were considered in analyses for all countries combined. 22·3
KW  - Colorectal cancer (Other)
KW  - Europe (Other)
KW  - Screening (Other)
KW  - Survival (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:35832063
C2  - pmc:PMC9272368
DO  - DOI:10.1016/j.lanepe.2022.100458
UR  - https://inrepo02.dkfz.de/record/180668
ER  -